| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/21/1999 | US5955086 Oregano for the treatment of internal parasites and protozoa |
| 09/21/1999 | US5955081 Antipsoriatic compositions, method of making, and method of using |
| 09/21/1999 | US5955062 Colored formulations for application to human skin |
| 09/21/1999 | US5955060 Cosmetics and veterinary medicine |
| 09/21/1999 | US5955059 Treating psoriasis, other skin disorders |
| 09/21/1999 | US5955058 Stabilized medicinal aerosol solution formulations containing ipratropium bromide |
| 09/21/1999 | US5954703 Method and apparatus for applying 5-aminolevulinic acid |
| 09/21/1999 | US5954675 Methyl nicotinate swabbed onto the skin |
| 09/21/1999 | CA2192975C Benzimidazolone derivatives |
| 09/21/1999 | CA2153454C Oil-in-water emulsion without surfactant, stabilized by hollow thermoplastic particles |
| 09/21/1999 | CA2152269C Process for preparing substituted 1,3-oxathiolanes with antiviral properties |
| 09/21/1999 | CA2135751C 4-mercaptoacetylamino-¬2| benzazepinone(3) derivatives, and use as enkephalinase inhibitors |
| 09/21/1999 | CA2127253C Composition to help stop smoking |
| 09/21/1999 | CA2086429C Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol |
| 09/21/1999 | CA2031880C Combined anti-inflammatory agent |
| 09/19/1999 | WO1999041256A1 Glucocorticoid-selective anti-inflammatory agents |
| 09/19/1999 | CA2320943A1 Glucocorticoid-selective anti-inflammatory agents |
| 09/18/1999 | CA2266091A1 Low-oxygen fluorocarbon as an agent for ophthalmology |
| 09/16/1999 | WO1999046575A2 Peptides containing a cholesterol recognition sequence and their uses |
| 09/16/1999 | WO1999046381A2 Human fgf gene and gene expression products |
| 09/16/1999 | WO1999046372A2 Ribozymes capable of inhibiting the expression of the ccr5 receptor |
| 09/16/1999 | WO1999046316A2 Enzyme inhibitors |
| 09/16/1999 | WO1999046284A2 Molecules that home to various selected organs or tissues |
| 09/16/1999 | WO1999046281A2 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | WO1999046280A1 Lipid compounds derived from sphingoid bases, preparation method and uses in cosmetics and dermopharmacy |
| 09/16/1999 | WO1999046279A2 INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 09/16/1999 | WO1999046275A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS) |
| 09/16/1999 | WO1999046273A1 Composition containing a precursor capable of being hydrolysed by glucocerebrosidase |
| 09/16/1999 | WO1999046272A1 Serine peptidase modulators |
| 09/16/1999 | WO1999046268A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 09/16/1999 | WO1999046262A1 Benzofurylpyrone derivatives |
| 09/16/1999 | WO1999046259A1 5-heteroaryl substituted indoles |
| 09/16/1999 | WO1999046258A1 SUBSTITUTED 2-(2,6-DIOXO-3-FLUOROPIPERIDIN-3-YL)-ISOINDOLINES AND THEIR USE TO REDUCE TNFα LEVELS |
| 09/16/1999 | WO1999046254A2 Amino anthracyclinone derivatives and their use in the treatment of amyloidosis |
| 09/16/1999 | WO1999046253A1 Heterocyclyl anthracyclinone derivatives |
| 09/16/1999 | WO1999046248A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 09/16/1999 | WO1999046245A2 PROCESSES FOR THE PREPARATION OF (R)-α- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL |
| 09/16/1999 | WO1999046242A1 Cycloalkene derivatives, process for producing the same, and use |
| 09/16/1999 | WO1999046241A1 Cytostatic agents |
| 09/16/1999 | WO1999046240A2 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 09/16/1999 | WO1999046237A1 Modulators of protein tyrosine phosphatases |
| 09/16/1999 | WO1999046232A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 09/16/1999 | WO1999045974A1 Protease inhibitors in absorbent articles |
| 09/16/1999 | WO1999045973A1 Disposable absorbent article having a skin care composition containing an enzyme inhibitor |
| 09/16/1999 | WO1999045970A1 Multicomponent complex for use with a substrate |
| 09/16/1999 | WO1999045966A1 Polynucleotide composition, method of preparation, and use thereof |
| 09/16/1999 | WO1999045963A1 Analgesic combination comprising nmda receptor antagonists and narcotic analgesics |
| 09/16/1999 | WO1999045960A1 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 09/16/1999 | WO1999045939A1 Fibrinogen receptor antagonists |
| 09/16/1999 | WO1999045935A1 Novel nucleoside analogs and uses in treating disease |
| 09/16/1999 | WO1999045933A1 Novel delivery of hydroxy carboxylic acids |
| 09/16/1999 | WO1999045932A1 Pharmaceutical composition based on natural synthesis progesterone and oestradiol and preparation method |
| 09/16/1999 | WO1999045931A1 Epiallopregnanolone in the treatment of cns disorders |
| 09/16/1999 | WO1999045929A1 The treatment of retinal edema with brinzolamide |
| 09/16/1999 | WO1999045928A1 IgE ANTIBODY PRODUCTION INHIBITORS AND AUTOIMMUNE DISEASES INHIBITORS |
| 09/16/1999 | WO1999045927A1 Vitronectin receptor antagonists |
| 09/16/1999 | WO1999045926A1 Condensed heterocyclic compounds as anti-inflammatory and immunomodulatory agents |
| 09/16/1999 | WO1999045925A1 Novel opiate compounds, methods of making and methods of use |
| 09/16/1999 | WO1999045924A1 Composition |
| 09/16/1999 | WO1999045923A1 Methods of inhibiting bone resorption |
| 09/16/1999 | WO1999045922A1 Lipoic acid analogs |
| 09/16/1999 | WO1999045921A1 Treatment of sunburn |
| 09/16/1999 | WO1999045920A2 The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation |
| 09/16/1999 | WO1999045919A1 Phenanthrofuran derivatives |
| 09/16/1999 | WO1999045918A1 Methods and compositions for delivery of taxanes |
| 09/16/1999 | WO1999045917A1 Remedies for aids |
| 09/16/1999 | WO1999045916A2 Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are affected |
| 09/16/1999 | WO1999045915A1 Use of alpha-rar antagonists for inhibition of mucin secretion |
| 09/16/1999 | WO1999045913A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions |
| 09/16/1999 | WO1999045912A1 Monoterpenoid derivatives for treatment of cancer |
| 09/16/1999 | WO1999045911A2 Universal reed-solomon coder-decoder |
| 09/16/1999 | WO1999045910A2 Methods and compositions for treating and preventing mucositis |
| 09/16/1999 | WO1999045909A2 Use of nitrone compounds for the inhibition of angiogenesis |
| 09/16/1999 | WO1999045908A2 Anti-viral uses of leflunomide products |
| 09/16/1999 | WO1999045907A2 Metal chelators for use in the treatment of alzheimer's disease |
| 09/16/1999 | WO1999045906A1 Treatment of compulsive behaviours in man and animals |
| 09/16/1999 | WO1999045905A2 Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists |
| 09/16/1999 | WO1999045902A1 Nicotine inhaler |
| 09/16/1999 | WO1999045900A1 Skin normalizing agents |
| 09/16/1999 | WO1999045887A2 Monolithic tablet for controlled drug release |
| 09/16/1999 | WO1999045886A2 New contraceptive kit for monotherapy |
| 09/16/1999 | WO1999045869A1 Use of corneal hardening agents in enzyme orthokeratology |
| 09/16/1999 | WO1999045797A1 Products containing polyphenol(s) and l-arginine to stimulate nitric oxide production |
| 09/16/1999 | WO1999045788A1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 09/16/1999 | WO1999045784A1 Bactericides |
| 09/16/1999 | WO1999045779A1 Novel compositions of eprosartan |
| 09/16/1999 | WO1999045776A1 Treatment of respiratory disease and otitis media |
| 09/16/1999 | WO1999036063A3 Vanadium (iv) metallocene complexes having spermicidal activity |
| 09/16/1999 | WO1999035243A3 Extension of cellular lifespan, methods and reagents |
| 09/16/1999 | WO1999034785A3 Treatment of dyskinesias |
| 09/16/1999 | WO1999033858A3 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 09/16/1999 | WO1999033431A3 Preparation and selection of pharmaceutically useful compounds from a diverse universal library |
| 09/16/1999 | WO1999033355A3 Fat blend |
| 09/16/1999 | WO1999032082A3 Pharmaceutical compositions |
| 09/16/1999 | WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 09/16/1999 | WO1999029321A9 Inhibition of membrane-associated viral replication |
| 09/16/1999 | WO1999028304A9 Pdgf receptor kinase inhibitory compounds, their preparation and compositions |
| 09/16/1999 | WO1999011249A3 Use of endipalene in the treatment of psoriasis |
| 09/16/1999 | WO1998056759A3 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same |
| 09/16/1999 | WO1998017230A3 New 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives |